TMO · Thermo Fisher Scientific Inc. · Webcasts, Transcripts & Audio
$700.22
+0.78 (+0.11%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$259.44B
Shares
370.52M
Volume · Nov 13
1.84M
Avg daily vol (3M)
2.13M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Thermo Fisher Scientific Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Thermo Fisher Scientific Inc. (TMO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-19
Thermo Fisher Scientific Inc. (TMO) November 19, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-21
Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript
Confident tone
Financial performance
Innovation and new product launches
2026 guidance
Revenue
$12.14B
▲ 9.1% YoY Diluted EPS
$4.64
▲ 8.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Thermo Fisher Scientific Inc. (TMO) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-23
Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript
Confident tone
Quarterly financial results
End market performance
Bioproduction and clinical research (PPD/Clario)
Revenue
$11.99B
▲ 10.5% YoY Diluted EPS
$4.68
▲ 9.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-05-20
Thermo Fisher Scientific Inc. (TMO) May 20, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-05-20
Thermo Fisher Scientific Inc. (TMO) May 20, 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-23
Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript
Positive tone
Strategic collaborations and M&A
Quarterly financial results
End market performance
Revenue
$11.01B
▲ 6.2% YoY Diluted EPS
$4.43
▲ 11.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-29
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript
Confident tone
Pharma and Biotech End Market
2026 Guidance and Outlook
Accelerator Drug Development / CDMO and CRO
Revenue
$12.21B*
▲ 7.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-22
Thermo Fisher Scientific Inc. (TMO) Q3 2025 Earnings Call Transcript
Confident tone
Strategic Collaboration with OpenAI
End Markets
PPD and Clinical Research Services
Revenue
$11.12B
▲ 4.9% YoY Diluted EPS
$4.27
▲ 0.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-23
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript
Positive tone
Tariffs and policy environment
Pharma and biotech end market
Trusted partner status and PPI Business System
Revenue
$10.86B
▲ 3% YoY Diluted EPS
$4.28
▲ 5.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript
Positive tone
Q1 strong financial execution
Bioproduction and pharma services demand
High-impact innovation and new products
Revenue
$10.36B
▲ 0.2% YoY Diluted EPS
$3.98
▲ 15% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-30
Thermo Fisher Scientific Inc. (TMO) Q4 2024 Earnings Call Transcript
Confident tone
Q4 and full-year financial results
Pharma services and Accelerator Drug Development
China business and environment
Revenue
$11.39B*
▲ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-23
Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript
Positive tone
Clinical research (PPD) and CRO trends
Pharma and biotech end market
Quarterly financial performance and EPS guidance raise
Revenue
$10.60B
▲ 0.2% YoY Diluted EPS
$4.25
▼ 3.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Thermo Fisher Scientific Inc. (TMO) Q2 2024 Earnings Call Transcript
Confident tone
PPI business system and operational execution
End market performance
Customer partnerships and commercial expansion
Revenue
$10.54B
▼ 1.4% YoY Diluted EPS
$4.04
▲ 15.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript
Confident tone
Quarterly financial performance
China and Biosecure Act risk
Raised guidance
Revenue
$10.35B
▼ 3.4% YoY Diluted EPS
$3.46
▲ 4.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-31
Thermo Fisher Scientific Inc. (TMO) Q4 2023 Earnings Call Transcript
Positive tone
Q4 and full year financial results
PPI business system and operational discipline
China market outlook and Biosecure Act
Revenue
$10.89B*
▼ 4.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Thermo Fisher Scientific Inc. (TMO) Q3 2023 Earnings Call Transcript
Revenue
$10.57B
▼ 1% YoY Diluted EPS
$4.42
▲ 16.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Thermo Fisher Scientific Inc. (TMO) Q2 2023 Earnings Call Transcript
Revenue
$10.69B
▼ 2.6% YoY Diluted EPS
$3.51
▼ 16.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Thermo Fisher Scientific Inc. (TMO) Q1 2023 Earnings Call Transcript
Revenue
$10.71B
▼ 9.4% YoY Diluted EPS
$3.32
▼ 40.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-01
Thermo Fisher Scientific Inc. (TMO) Q4 2022 Earnings Call Transcript
Revenue
$11.45B*
▲ 7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Thermo Fisher Scientific Inc. (TMO) Q3 2022 Earnings Call Transcript
Revenue
$10.68B
▲ 14.4% YoY Diluted EPS
$3.79
▼ 20.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Thermo Fisher Scientific Inc. (TMO) Q2 2022 Earnings Call Transcript
Revenue
$10.97B
▲ 18.3% YoY Diluted EPS
$4.22
▼ 8.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Thermo Fisher Scientific Inc. (TMO) Q1 2022 Earnings Call Transcript
Revenue
$11.82B
▲ 19.3% YoY Diluted EPS
$5.61
▼ 4.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-02
Thermo Fisher Scientific Inc. (TMO) Q4 2021 Earnings Call Transcript
Revenue
$10.70B*
▲ 1.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-27
Thermo Fisher Scientific Inc. (TMO) Q3 2021 Earnings Call Transcript
Revenue
$9.33B
▲ 9.5% YoY Diluted EPS
$4.79
▼ 1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Thermo Fisher Scientific Inc. (TMO) Q2 2021 Earnings Call Transcript
Revenue
$9.27B
▲ 34.1% YoY Diluted EPS
$4.61
▲ 59% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Thermo Fisher Scientific Inc. (TMO) Q1 2021 Earnings Call Transcript
Revenue
$9.91B
▲ 59% YoY Diluted EPS
$5.88
▲ 198.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-01
Thermo Fisher Scientific Inc. (TMO) Q4 2020 Earnings Call Transcript
Revenue
$10.55B*
▲ 54.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-21
Thermo Fisher Scientific Inc. (TMO) Q3 2020 Earnings Call Transcript
Revenue
$8.52B
▲ 35.9% YoY Diluted EPS
$4.84
▲ 157.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-06
Thermo Fisher Scientific Inc. (TMO) Q2 2020 Earnings Call Transcript
Revenue
$6.92B
▲ 9.5% YoY Diluted EPS
$2.90
▲ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-06
Thermo Fisher Scientific Inc. (TMO) Q1 2020 Earnings Call Transcript
Revenue
$6.23B
▲ 1.7% YoY Diluted EPS
$1.97
▼ 2.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-30
Thermo Fisher Scientific Inc. (TMO) Q4 2019 Earnings Call
Revenue
$6.83B
▲ 4.9% YoY Diluted EPS
$2.49
▲ 12.2% YoY Gross margin
44.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–32 of 32 webcasts
Key facts
CIK
97745
CUSIP
883556102
13F (30d)
2215 filings
2101 filers
Visit website
Investor relations